Showing results (121-130 of 141) with videos related to

Sort By:
Pageof 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2011
Multi-institutional phase II study of selumetinib in patients with metastatic biliary cancersTanios Bekaii-Saab, Mitch A Phelps, Xiaobai Li, et al.
JCO Precision Oncology|July 9, 2025
Germline <i>POT1</i> Variants in a Pan-Cancer CohortPamela L Brock, Morgan Webster, Sandya Liyanarachchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2023
Combined Vorinostat and Chloroquine Inhibit Sodium-Iodide Symporter Endocytosis and Enhance Radionuclide Uptake In VivoMartin L Read, Katie Brookes, Ling Zha, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 6, 2020
Assessing thyroid cancer risk using polygenic risk scoresSandya Liyanarachchi, Julius Gudmundsson, Egil Ferkingstad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
Phase II clinical trial of sorafenib in metastatic medullary thyroid cancerElaine T Lam, Matthew D Ringel, Richard T Kloos, et al.
Cancers|October 13, 2021
<i>RAC1</i> Alterations Induce Acquired Dabrafenib Resistance in Association with Anaplastic Transformation in a Papillary Thyroid Cancer PatientRozita Bagheri-Yarmand, Naifa L Busaidy, Elena McBeath, et al.
Thyroid : Official Journal of the American Thyroid Association|August 22, 2025
2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid CancerMatthew D Ringel, Julie Ann Sosa, Zubair Baloch, et al.
The Journal of Clinical Endocrinology and Metabolism|September 22, 2005
BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancerMingzhao Xing, William H Westra, Ralph P Tufano, et al.
The Journal of Clinical Endocrinology and Metabolism|March 30, 2013
SRGAP1 is a candidate gene for papillary thyroid carcinoma susceptibilityHuiling He, Agnieszka Bronisz, Sandya Liyanarachchi, et al.
Ebiomedicine|February 12, 2026
Disulfiram metabolite Cu(DDC)<sub>2</sub> enhances radionuclide uptake in vivo revealing insights into tumoural ablation resistanceKatie Brookes, Jessica S Fear, Caitlin E M Thornton, et al.
Pageof 15